April 24 (Reuters) - Medical device maker Boston
Scientific ( BSX ) raised its annual profit forecast on
Wednesday as the company banks on resilient demand for its heart
devices, with post-pandemic elective surgical procedures picking
up pace.
The company now expects 2024 adjusted earnings per share
between $2.29 and $2.34, compared with its previous forecast of
$2.23 to $2.27 per share.